Delivery Order SPE2DB22D1200-SPE2DB25FN3VF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,337.70 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg on September 16, 2025, with completion scheduled for September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication primarily used to treat attention-deficit/hyperactivity disorder...
- The Defense Logistics Agency awarded a delivery order valued at $2,189.62 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Vyvanse 30 mg capsules (100 count). This non-set-aside, firm fixed price delivery order is scheduled for ultimate completion on August 6, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and binge eating disorder,...
- The Defense Logistics Agency awarded a delivery order valued at $1,407.17 to AmerisourceBergen Drug Corp for Vyvanse 40 mg capsules (100-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication commonly used in military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,676.98 to AmerisourceBergen Drug Corp for Vyvanse 50 mg capsules (100 count) on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside contract represents a firm fixed-price delivery order to be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription medication commonly used in military and veteran healthcare systems for the treatment of...
- The Defense Logistics Agency awarded a $1,754.54 firm fixed price delivery order to AmerisourceBergen Drug Corp for Vyvanse 30 mg capsules (100 count) on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $1,941.61 to AmerisourceBergen Drug Corp for Vyvanse 60 mg capsules (100 count) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication commonly used in military and veteran healthcare systems for...
- The Defense Logistics Agency awarded a delivery order valued at $4,991.73 to AmerisourceBergen Drug Corp for the supply of Vyvanse 50 mg capsules (100 count) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania facility. Vyvanse is a prescription stimulant medication commonly used to treat attention deficit...
- The Defense Logistics Agency awarded a delivery order valued at $6,321.44 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription medication used in the treatment of attention deficit hyperactivity...
- The Defense Logistics Agency awarded a $1,798.76 delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse 50 mg capsules (100-count units) under a firm fixed price contract. This non-set-aside award was issued on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication commonly used in military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,775.04 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vyvanse is a prescription medication commonly used to treat attention-deficit/hyperactivity disorder and binge...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB25FN3VFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,601.50 to AmerisourceBergen Drug Corp for Vyvanse 30 mg capsules (100 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order represents a non-competitive set-aside transaction and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder and binge eating disorder, making this procurement consistent with the Defense Health Agency's pharmaceutical supply needs for military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. As the prime contractor on this comprehensive global pharmaceutical support vehicle, AmerisourceBergen Drug Corp supplies a broad portfolio of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's extensive federal contracting history and competitive capabilities position it as a critical pharmaceutical distributor within the Defense Logistics Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/14/25 |